Blog

May 05, 2023

Convatec, Beta Bionics partner on iLet bionic pancreas

May 25, 2023 By Sean Whooley FDA last week cleared the Beta Bionics iLet ACE

May 25, 2023 By Sean Whooley

FDA last week cleared the Beta Bionics iLet ACE automated insulin pump and iLet dosing decision software.

Convatec offers design and manufacturing services for infusion set technologies and insertion devices for insulin pump treatment. Beta Bionics’ iLet uses its inset and contact detach infusion sets for subcutaneous insulin administration.

The company's inset, an all-in-one infusion set with a built-in insertion device, connects to iLet on one end and the infusion site at the other. It features a soft, indwelling cannula. Convatec's contact detach comes with a thin, stainless steel needle. Both infusion sets use kink-free infusion tubing to ensure uninterrupted insulin infusion. They also feature a skin-friendly adhesive tape to secure the set firmly at the infusion site.

Get the full story at our sister site, Drug Delivery Business News.

Filed Under: Business/Financial News, Diabetes, Drug Pumps, Drug-Device Combinations, Health Technology, Patient Monitoring, Software / IT Tagged With: Beta Bionics, ConvaTec